
News|Articles|September 23, 2026
FAQ: How should pediatricians hand off teens with diabetes?
Author(s)Contemporary Pediatrics Staff
Fact checked by: Morgan Ebert, Executive Editor
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Advertisement
Advertisement
The International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Association for the Study of Diabetes (EASD), and the American Diabetes Association (ADA) have released a joint consensus report on the transition of adolescents and young adults with diabetes from pediatric to adult diabetes care. The report is being published simultaneously in Diabetologia, Hormone Research in Paediatrics, and Diabetes Care, and it was approved by the boards of all 3 organizations.
Related to this article

FDA authorized Abbott's Libre Duo 10 Day, the first wearable that continuously tracks glucose and ketones, for patients 2 and older with diabetes.

Spot pediatric cancer red flags in everyday symptoms, avoid steroid missteps, act fast on emergencies, and guide survivors with smart follow-up.

Semaglutide cut testosterone by half in early trial data — but one patient's rapid weight loss revealed a real risk. Our experts weigh the promise of GLP-1 therapy against how fast is too fast for teens.

Which labs actually change management? Our experts debate fasting insulin versus A1c, explain why total testosterone can mislead, and share the LH-to-FSH trick that helps settle ambiguous cases.

Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.

Ovarian ultrasound doesn't apply to teens. Our experts walk through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.

A global Lancet consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.
Advertisement
Advertisement

